A. Kolaro6ic et al. / Tetrahedron Letters 42 (2001) 2579–2582
2581
R
R
OH
OH
HN
NH2
O
HN
H2/Pd/C
1%HCl
Pb(OAc)4
MeOH
Ar
COOH
VIa-d
Ar
COOH
VIIa,b,d
Ar
COOH
IIIa-d
Scheme 4.
After removal of the activating carbonyl group, we
were able to prepare stable amino acids VIa–d with
negligible epimerization (Scheme 4).§ Derivative VIc
afforded suitable crystals of the hemihydrate and there-
after the absolute stereochemistry was assigned by
single crystal X-ray analysis (Fig. 1).¶
In the case of leucinol and aminobutanol derivatives
VIa,b the sense of asymmetric induction has been deter-
mined after their transformation to the known
homophenylalanines VIIa,b using a convenient oxida-
tive degradation with Pb(OAc)4 (Scheme 4).7 Amino
acids VIIa,b were identified and their enantiomeric
purity was determined by HPLC on a chiral CROWN-
PAK® CR(+) column.
Figure 1. ORTEP view of the molecular structure of VIc
(50% probability thermal ellipsoids).
added to ethyl benzoylacrylate.2 (S)-Prolinol (IIc), sur-
prisingly, represents a special case and forms the amino
acid IIIc with the (S,S)-configuration.
In summary, the highly stereoselective conjugate addi-
tion of chiral amino alcohols described here represents
a simple synthetic route to both antipodes of a variety
of N-functionalized homophenylalanine derivatives.
The application of this method to other conjugate
systems is currently in progress.
The absolute configuration of the adducts IIIa–d could
not be assigned by the usual spectroscopic methods. In
order to determine the configuration of the newly-built
stereogenic center in derivatives IIIa–d we therefore
used three different methods.
For the adducts it is distinctive that they are on the one
hand thermolabile, on the other unstable both in alka-
line and neutral medium. However, we succeeded in
finding mild acidic conditions for transformation of
adducts IIIb,d into the corresponding lactones (Scheme
3), leading to pure compounds via precipitation.‡ After
simple isolation of these sensitive compounds we suc-
ceeded in elucidating the absolute configuration of
adduct IIId by NOE. In the case of amino acid IIIb we
failed due to signal overlap.
§ A typical procedure for preparation of VIa is as follows: Amino acid
IIIa (2.46 g, 8.3 mmol) was dissolved in 1% HCl (75 ml) and 10%
Pd/C was added (0.50 g). The suspension was stirred under H2 (1.1
atm) for 1 day. Thereafter the catalyst was filtered off and washed
with 1% HCl (50 ml). The resulting solution was added to the
filtrate, partially concentrated under reduced pressure and its pH
adjusted to 6.5 with 1N NaOH. A precipitate was filtered off,
washed with Et2O and dried to afford 1.71 g (73%) of amino acid
VIa (d.r. >95:5) as a white solid. An analytical sample was obtained
by recrystallization from EtOH with several drops of water: mp
220–222°C, 1H NMR (300 MHz, CD3OD, DCl/TMS): 7.21 (m, 2H,
H-arom.); 6.89 (m, 2H, H-arom.); 4.12 (‘t’, 1H, J2,3A=6.3 Hz,
‡ A typical procedure for the preparation of Vd is as follows: Amino
acid IIId (980 mg, 3 mmol) was dissolved in a mixture of THF (50
ml) and 96% H2SO4 (310 mg, 3 mmol). The mixture was stirred for
3 days at room temperature. A precipitate was filtered off and dried
to afford 730 mg (60%) of Vd as a white solid (mp 185–188°C; d.r.
>95:5). 1H NMR (300 MHz, DMSO-d6/TMS): 8.05 (m, 2H, H-
arom.); 7.73 (m, 1H, H-arom.); 7.60 (m, 2H, H-arom.); 7.35 (m, 5H,
H-arom.); 4.69 (dd, 1H, J3,1%A=3.7 Hz, J3,1%B=4.4 Hz, H-3); 4.63
(dd, 1H, J6A,6B=12.1 Hz, J6A,5=12.1 Hz, H-6A); 4.45 (dd, 1H,
J
2,3B=6.3 Hz, H-2); 3.83 (dd, 1H, J1%A,2%=3.3 Hz, J1%A,1%B=12.4 Hz,
H-1%A); 3.79 (s, 3H, OMe); 3.72 (dd, 1H, J1%B,2%=5.6 Hz, J1%A,1%B
=
12.4 Hz, H-1%B); 3.15–3.25 (m, 1H, H-2%); 2.82 (m, 1H, H-3A); 2.74
(m, 1H, H-3B); 2.26 (m, 2H, H-4); 1.76 (dq, 2H, J3%,4%=7.4 Hz,
J2%,3%=7.4 Hz, H-3%); 1.01 (t, 3H, J3%,4%=7.4 Hz, H-4%); 13C NMR (75
MHz, CD3OD, DCl/TMS): 171.4 (C-1); 159.8, 133.1, 130.5, 115.1
(C-arom.); 62.4 (C-2%); 59.9 (C-1%); 58.4 (C-2); 55.8 (OMe); 33.1
(C-3); 31.3 (C-4); 21.5 (C-3%); 10.4 (C-4%).
¶ Crystal data for VIc: C30H44N2O7, M=544.67, 0.03×0.06×0.50 mm,
monoclinic, space group P21/a (No. 14), a=11.442(3), b=7.390(2),
J
6A,6B=12.1 Hz, J6B,5=2.8, Hz, H-6B); 4.17–4.29 (m, 1H, H-5);
3.99 (dd, 1H, J1%A,1%B=19.0 Hz, J3,1%A=4.4 Hz, H-1%A); 3.82 (dd,
1H, 1%A,1%B=19.0 Hz, 3,1%B=3.7 Hz, H-1%B); 3.08 (dd, 1H,
3
,
,
c=16.861(4) A, i=95.313(5)°, V=1419.6(6) A , Z=2, Dc=1.274 g
cm−3, v(Mo Ka)=0.90 cm−1, T=298 K, 2qmax=46.62°, 8169 reflec-
tions measured, 3952 unique (Rint=0.0423). The refinement (362
variables, three restrictions) based on F converged with R=0.0446,
Rw=0.0683, and GOF=0.940 using 2911 unique reflections (I>
2|(I)).
J
J
J
1¦A,1¦B=13.9 Hz, J5,1¦A=6.0 Hz, H-1¦A); 2.95 (dd, 1H, J1¦A,1¦B=
13.9 Hz, J5,1¦B=8.3 Hz, H-1¦B); 13C NMR (75 MHz, DMSO-d6/
TMS): 196.1 (C-2%); 165.9 (C-2); 135.0, 135.0, 134.5, 129.4, 129.1,
128.9, 128.5, 127.4 (C-arom.); 68.5 (C-6); 53.1 (C-5); 51.4 (C-3); 39.4
(C-1%); 33.7 (C-1¦).